John S. Sampalis, B.Sc., B.A. (Hon.),
M.Sc., Ph.D., F.A.C.E.
CEO and Chief Scientific Officer
Dr. Sampalis is a clinical epidemiologist with
undergraduate training in Microbiology, Immunology and
Neuroscience and graduate training in Clinical Epidemiology
and Biostatistics (M.Sc. and Ph.D.) from McGill University.
Currently a tenured Associate Professor of Surgery and
Epidemiology & Biostatics with the Faculty of Medicine of
McGill University, he also holds equivalent appointments
with the Faculties of Medicine at Laval University and the
University of Montreal.
Possessing extensive expertise in health services research,
clinical trials and the evaluation of medical technology,
Dr. Sampalis also offers services as a Research and
Epidemiological Consultant for numerous pharmaceutical
companies, hospitals and government organizations and
agencies. With 100 peer reviewed publications and 100
presentations to date and over $6.5 million dollars in
federal and provincial research grants awarded, Dr. Sampalis
is recognized as one of Canada’s leading epidemiologist, as
well as the top trauma researcher in Canada. Currently, he
holds a Medical Scientist Salary Award from the Medical
Research Council of Canada and has previously received
numerous prestigious scholarships and awards including the
National Health Research and Development Scholar from Health
Canada. Dr. Sampalis currently participates as a reviewer
for over five leading peer reviewed journals and as a
committee member for provincial and federal funding
agencies.
Stella Boukas, BA, CCRP
Vice President of Clinical Operations
Ms. Boukas has a Bachelor’s degree in Psychology from McGill University as well as training in Epidemiology and Biostatistics. Her extensive experience in medical research management includes Clinical Trials, Observational Studies, Chart Reviews and Literature Reviews. Ms. Boukas has been working with JSS since its birth in the 80s.
Toni Rinow, Ph.D., MBA
Chief Financial Officer
Toni Rinow holds a doctorate in physical chemistry from
the University of Montreal. In addition, she completed an
engineering degree in chemistry from École Nationale
Supérieure d'Ingénieur in Strasbourg, France. Dr. Rinow
completed her training with a Management of Business
Administration degree (MBA) from McGill University in
Montreal. She was born in Hamburg, Germany.
Her professional career is focused on business development,
sales and financing of companies. She was involved in
transitioning two biotechnology companies to an initial
public offering at the Toronto Stock Exchange. She also
oversaw a life science investment portfolio with 400 million
dollar under management. Dr. Rinow was involved in the
negotiation of international corporate alliances worth over
100 million dollars.
Sebastien Dupuis, BSc, MBA
Senior Director of Contract Management & Proposal
Development
An MBA graduate from the Écoles des Hautes Études Commerciales (HEC), Mr. Dupuis has more than 5 years of experience in the Life Science industry.
Sanjay Machado, Ph.D.
Executive Director, Global Business Operations
Dr. Machado has over 16 years of experience in multinational pharmaceutical, CRO, Bioequivalence & Phase I and Site Management Organizations. Prior to JSS Medical Research Inc., he founded Venn Life Sciences and served as the Chief Operating Officer of the company. He also held increasing management positions in the field at ICON Clinical Research plc, ADA Medical Ltd, AstraZeneca & Biovail Contract Research. Dr. Machado has worked on products in several therapeutic areas including; Gastroenterology, CVS, Respiratory, Dermatology, Endocrinology, Obstetrics & Gynecology, Oncology, Radiology, Psychiatry and CNS. He also has clinical experience in generic drug development, medical devices and radio nuclear imaging studies. He has organized and managed a Site Management Organization developing qualified and trained staff, Investigators and Investigator Sites. He created, presented & positioned new business opportunities for the SMO for further growth. Dr. Machado obtained his MD from University of Pune, India. He specialized in family medicine and held private practice. He has authored several publications, abstracts, and posters at international conferences.
Marianna Boukas, BA
Senior
Director of Quality Assurance
Aside from her Bachelor’s degree from McGill University, Ms. Boukas has completed a Certificate for Technical Communications at Concordia University. While implementing the JSS Quality Assurance Program, she has also received compliance training from SNC Lavalin Pharma (SLP). Ms. Boukas has more than twenty years of experience working in a hospital setting, which provides a strong foundation for the continuous development of the JSS Quality Assurance system.
Wael Sedky, BSc, BEng
Director of Information Technology
Mr. Sedky has a Bachelor’s degree in Engineering from the Arab Maritime Transport Academy in Alexandria, Egypt and a Bachelor of Computer Science degree from Bishop’s University in Quebec, Canada. His qualifications include Net programming, Validation of Computerized systems, GDP and GCP as well as experience in Network Administration, Programming, Technical Support and training.
Fridon Chouha, M.B.Ch.B.,
Director, Medical Liaison
Dr. Chouha is a graduate from the medical school at the University of Alexandria in Egypt. He recently spent twenty years at Merck Frosst Canada in various roles in clinical research, health science services and sales / hospital services. As the Medical Director at JSS, Dr. Chouha is the primary consultant of all medical aspects of most studies including design and preparation of study protocols and research proposals.
Andreas Nikolis,
Director of Surgical Research
Dr. Nikolis is currently attending faculty at the Centre
Hospitalier de l'Université de Montreal (CHUM) in the
Division of Plastic and Reconstructive Surgery. His training
includes General Surgery (McGill University, 1996-2000),
Plastic and Reconstructive Surgery (Université de Montreal,
2000-2002), Craniofacial Reconstructive Surgery (Institute
for Craniofacial and Reconstructive Surgery, Michigan,
2002-2003), as well as a MSc in Experimental Surgery (McGill
University,1999-2001).
His current clinical interests include secondary correction
of congenital craniofacial syndromes, microvascular free
tissue reconstruction, upper extremity reimplantation
surgery, vascular malformations, chronic wound healing,
reconstructive surgery following oncologic ablation and
trauma. His research interests include cost benefit
evaluations of new surgical technologies, quality of life
assessment following surgical intervention, as well as short
and long term outcomes following treatment regimens
Moishe Liberman, M.D., Ph. D., FRCSC
Dr. Liberman completed his MD, PhD, general surgery
residency and post-graduate studies at McGill University and
its MUHC hospital network. During his studies, he quickly
distinguished himself as a J.W. McConnell Foundation
scholar. He was recognized as outstanding surgery resident
and teacher by the McGill Faculty of Medicine in 2005 and
2006.
He left for the United States to undertake subspecialty
training in thoracic and airway surgery. From 2006 to 2009,
he completed a clinical fellowship at the Harvard School of
Medicine and its affiliated Massachusetts General Hospital.
He spent additional time training at the Mayo Clinic in
Rochester, Minnesota, as well at the Beth Israel Deaconess
Hospital in Boston. He also received additional subspecialty
training in airway and esophageal ultrasound and endoscopy.
An esophageal intervention
Dr. Liberman is member to several professional associations
from the American College of Surgeons to the Canadian
Medical Association. He has received research grants from
Canada Foundation for Innovation, the Fonds de recherce en
santé du Québec, the Canadian Institutes for Health
Research, and the Society of University Surgeons. His
peer-reviewed research has examined topics such as
cardiovascular and thoracic surgery, trauma units, gastric
bypass, cardiopulmonary resuscitation, airway injuries in
professional hockey players and the impact of hospital
waiting times on heart patients.
Andre Lavoie,
Epidemiologist
Dr. Lavoie is an Epidemiologist with undergraduate training in Sociology, and graduate training in Demography (MSc) from the University of Montreal and Epidemiology and Biostatistics from McGill University

The pledge to deliver irreproachable quality...
"Our goal is to become a preferred provider of research services to healthcare stakeholders including industry, hospitals and government agencies..."

JSS Medical Research Inc. is a Clinical Research Organization that conducts Phase II to Phase IV clinical trials on behalf of pharmaceutical, biotech and nutraceutical companies. The organization responds to the evolving needs of the health stakeholders for high quality, scientifically rigorous and sound clinical research services.




